Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Morris Schambelan, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address1001 Potrero Ave, SFGH 100
    San Francisco CA 94143
    Phone415-206-3351

       ORNG Applications 
       Websites
       Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Khanijow K, Unemori P, Leslie KS, Mulligan K, Schambelan M, Maurer T. Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy. Dermatol Res Pract. 2013; 2013:941740.
        View in: PubMed
      2. Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. J Bone Miner Res. 2013 Mar; 28(3):700-8.
        View in: PubMed
      3. Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K. Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS Res Treat. 2012; 2012:103072.
        View in: PubMed
      4. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011 Jul; 12(6):403-9.
        View in: PubMed
      5. Winterstein AG, Heckbert SR, Schambelan M. Intensive glucose lowering and cardiovascular outcomes. N Engl J Med. 2011 Jun 9; 364(23):2263; author reply 2264.
        View in: PubMed
      6. Masharani UB, Maddux BA, Li X, Sakkas GK, Mulligan K, Schambelan M, Goldfine ID, Youngren JF. Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle. PLoS One. 2011; 6(5):e19878.
        View in: PubMed
      7. Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, Mulligan K, Schambelan M. Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PLoS One. 2011; 6(2):e14709.
        View in: PubMed
      8. Taylor SA, Lee GA, Pao VY, Anthonypillai J, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers. J Acquir Immune Defic Syndr. 2010 Nov; 55(3):361-4.
        View in: PubMed
      9. Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. J Clin Endocrinol Metab. 2010 Sep; 95(9):4361-6.
        View in: PubMed
      10. Shrestha S, Irvin MR, Taylor KD, Wiener HW, Pajewski NM, Haritunians T, Delaney JA, Schambelan M, Polak JF, Arnett DK, Chen YD, Grunfeld C. A genome-wide association study of carotid atherosclerosis in HIV-infected men. AIDS. 2010 Feb 20; 24(4):583-92.
        View in: PubMed
      11. Pao VY, Lee GA, Taylor S, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. AIDS. 2010 Jan 16; 24(2):265-70.
        View in: PubMed
      12. Sakkas GK, Schambelan M, Mulligan K. Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting? Curr Opin Clin Nutr Metab Care. 2009 Nov; 12(6):623-7.
        View in: PubMed
      13. Campos GM, Rabl C, Peeva S, Ciovica R, Rao M, Schwarz JM, Havel P, Schambelan M, Mulligan K. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010 Jan; 14(1):15-23.
        View in: PubMed
      14. Lee GA, Schwarz JM, Patzek S, Kim S, Dyachenko A, Wen M, Mulligan K, Schambelan M, Grunfeld C. The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men. J Acquir Immune Defic Syndr. 2009 Oct 1; 52(2):246-8.
        View in: PubMed
      15. Sakkas GK, Mulligan K, Dasilva M, Doyle JW, Khatami H, Schleich T, Kent-Braun JA, Schambelan M. Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study. PLoS One. 2009; 4(2):e4605.
        View in: PubMed
      16. Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab. 2009 Apr; 94(4):1137-44.
        View in: PubMed
      17. Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D'Agostino RB, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation. 2008 Jul 8; 118(2):e48-53.
        View in: PubMed
      18. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008 Jul 8; 118(2):198-210.
        View in: PubMed
      19. Lee GA, Rao M, Mulligan K, Lo JC, Aweeka F, Schwarz JM, Schambelan M, Grunfeld C. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS. 2007 Oct 18; 21(16):2183-90.
        View in: PubMed
      20. Li X, Youngren JF, Hyun B, Sakkas GK, Mulligan K, Majumdar S, Masharani UB, Schambelan M, Goldfine ID. Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magn Reson Imaging. 2008 Feb; 26(2):188-97.
        View in: PubMed
      21. Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab. 2007 Feb; 92(2):563-70.
        View in: PubMed
      22. Lee GA, Lo JC, Aweeka F, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Clin Infect Dis. 2006 Sep 1; 43(5):658-60.
        View in: PubMed
      23. Lo JC, Kazemi MR, Hsue PY, Martin JN, Deeks SG, Schambelan M, Mulligan K. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection. Clin Infect Dis. 2005 Nov 1; 41(9):1335-40.
        View in: PubMed
      24. Schwarz JM, Lee GA, Park S, Noor MA, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M, Grunfeld C. Indinavir increases glucose production in healthy HIV-negative men. AIDS. 2004 Sep 3; 18(13):1852-4.
        View in: PubMed
      25. Lo JC, Mulligan K, Noor MA, Lee GA, Schwarz JM, Grunfeld C, Schambelan M. The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Clin Infect Dis. 2004 Sep 1; 39(5):732-5.
        View in: PubMed
      26. Lee GA, Mafong DD, Noor MA, Lo JC, Mulligan K, Schwarz JM, Schambelan M, Grunfeld C. HIV protease inhibitors increase adiponectin levels in HIV-negative men. J Acquir Immune Defic Syndr. 2004 May 1; 36(1):645-7.
        View in: PubMed
      27. Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C. The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS. 2004 Mar 5; 18(4):641-9.
        View in: PubMed
      28. Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR. Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 2003; 4(10):R61.
        View in: PubMed
      29. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003 Aug 19; 139(4):258-66.
        View in: PubMed
      30. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002 Nov 1; 31(3):257-75.
        View in: PubMed
      31. Tai VW, Schambelan M, Algren H, Shayevich C, Mulligan K. Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting. Clin Infect Dis. 2002 Nov 15; 35(10):1258-62.
        View in: PubMed
      32. Mulligan K, Schambelan M. Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol. 2002 Sep; 85(1):151-9.
        View in: PubMed
      33. Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M, McCune JM. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS. 2002 May 24; 16(8):1103-11.
        View in: PubMed
      34. Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002 Mar 29; 16(5):F1-8.
        View in: PubMed
      35. Schwarz JM, Mulligan K, Lee J, Lo JC, Wen M, Noor MA, Grunfeld C, Schambelan M. Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab. 2002 Feb; 87(2):942.
        View in: PubMed
      36. Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen RA, Grunfeld C, Schambelan M. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab. 2001 Aug; 86(8):3480-7.
        View in: PubMed
      37. Lo JC, Schambelan M. Reproductive function in human immunodeficiency virus infection. J Clin Endocrinol Metab. 2001 Jun; 86(6):2338-43.
        View in: PubMed
      38. Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS. 2001 May 4; 15(7):F11-8.
        View in: PubMed
      39. Mulligan K, Tai VW, Algren H, Abrams DI, Leiser RJ, Lo JC, Schambelan M. Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr. 2001 Apr 15; 26(5):443-8.
        View in: PubMed
      40. Kaplan G, Thomas S, Fierer DS, Mulligan K, Haslett PA, Fessel WJ, Smith LG, Kook KA, Stirling D, Schambelan M. Thalidomide for the treatment of AIDS-associated wasting. AIDS Res Hum Retroviruses. 2000 Sep 20; 16(14):1345-55.
        View in: PubMed
      41. Giacchetti G, Sechi LA, Griffin CA, Don BR, Mantero F, Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens. 2000 Jun; 18(6):695-702.
        View in: PubMed
      42. Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr. 2000 Jan 1; 23(1):35-43.
        View in: PubMed
      43. Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold KR, Grunfeld C. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1999 Dec; 48(12):1524-31.
        View in: PubMed
      44. Mulligan K, Tai VW, Schambelan M. Use of growth hormone and other anabolic agents in AIDS wasting. JPEN J Parenter Enteral Nutr. 1999 Nov-Dec; 23(6 Suppl):S202-9.
        View in: PubMed
      45. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA. 1999 Apr 14; 281(14):1275-81.
        View in: PubMed
      46. Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I, Leder P. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell. 1999 Mar 5; 96(5):689-700.
        View in: PubMed
      47. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. Body shape changes in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1; 19(3):307-8.
        View in: PubMed
      48. Engler MM, Schambelan M, Engler MB, Ball DL, Goodfriend TL. Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc Soc Exp Biol Med. 1998 Jul; 218(3):234-7.
        View in: PubMed
      49. Johansen KL, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol. 1998 Jun; 9(6):1080-4.
        View in: PubMed
      50. Mulligan K, Tai VW, Schambelan M. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study. J Clin Endocrinol Metab. 1998 May; 83(5):1542-7.
        View in: PubMed
      51. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet. 1998 Mar 21; 351(9106):867-70.
        View in: PubMed
      52. Sechi LA, Griffin CA, Zingaro L, Catena C, De Carli S, Schambelan M, Bartoli E. Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats. Am J Hypertens. 1997 Nov; 10(11):1223-30.
        View in: PubMed
      53. Deeks SG, Coleman RL, White R, Pachl C, Schambelan M, Chernoff DN, Feinberg MB. Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. J Infect Dis. 1997 Aug; 176(2):514-7.
        View in: PubMed
      54. Sechi LA, Griffin CA, Zingaro L, Valentin JP, Bartoli E, Schambelan M. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats. Diabetologia. 1997 Jul; 40(7):770-7.
        View in: PubMed
      55. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1; 15(1):43-8.
        View in: PubMed
      56. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. The renin-angiotensin system and compensatory renal hypertrophy in the rat. Am J Hypertens. 1997 Apr; 10(4 Pt 1):397-402.
        View in: PubMed
      57. Mulligan K, Tai VW, Schambelan M. Energy expenditure in human immunodeficiency virus infection. N Engl J Med. 1997 Jan 2; 336(1):70-1.
        View in: PubMed
      58. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E. Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia. 1997 Jan; 40(1):23-9.
        View in: PubMed
      59. Griffin CA, Giacchetti G, Schambelan M, Sechi LA. Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat. Nephron. 1997; 76(1):103-10.
        View in: PubMed
      60. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med. 1996 Dec 1; 125(11):873-82.
        View in: PubMed
      61. Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, Farese RV. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A. 1996 Nov 26; 93(24):14041-6.
        View in: PubMed
      62. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension. 1996 Sep; 28(3):403-8.
        View in: PubMed
      63. Benowitz NL, Zevin S, Carlsen S, Wright J, Schambelan M, Cheitlin M. Orthostatic hypertension due to vascular adrenergic hypersensitivity. Hypertension. 1996 Jul; 28(1):42-6.
        View in: PubMed
      64. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med. 1996 Apr 15; 124(8):708-16.
        View in: PubMed
      65. Sechi LA, Griffin CA, Giacchetti G, Zingaro L, Catena C, Bartoli E, Schambelan M. Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension. 1996 Apr; 27(4):955-61.
        View in: PubMed
      66. Jeunemaitre X, Charru A, Pascoe L, Guyene TT, Aupetit-Faisant B, Shackleton CH, Schambelan M, Plouin PF, Corvol P. [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. Presse Med. 1995 Sep 23; 24(27):1243-8.
        View in: PubMed
      67. Sechi LA, Valentin JP, Griffin CA, Lee E, Bartoli E, Humphreys MH, Schambelan M. Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1995 Jun; 95(6):2451-7.
        View in: PubMed
      68. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994 Nov 4; 79(3):407-14.
        View in: PubMed
      69. Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes. 1994 Oct; 43(10):1180-4.
        View in: PubMed
      70. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. [Gene expression of the renin-angiotensin system in compensatory renal hypertrophy secondary to contralateral nephrectomy]. Arch Mal Coeur Vaiss. 1994 Aug; 87(8):1115-7.
        View in: PubMed
      71. Schambelan M. Licorice ingestion and blood pressure regulating hormones. Steroids. 1994 Feb; 59(2):127-30.
        View in: PubMed
      72. Sechi LA, Griffin CA, Schambelan M. Effect of dietary sodium chloride on insulin receptor number and mRNA levels in rat kidney. Am J Physiol. 1994 Jan; 266(1 Pt 2):F31-8.
        View in: PubMed
      73. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol. 1993 Dec; 4(6):1337-45.
        View in: PubMed
      74. Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M. Renin-angiotensin system gene expression during compensatory renal hypertrophy in the rat. J Hypertens Suppl. 1993 Dec; 11(5):S236-7.
        View in: PubMed
      75. Sechi LA, Griffin CA, De Carli S, Sechi G, Schambelan M, Bartoli E. [Angiotensin II receptors in the heart conduction tissue]. Minerva Cardioangiol. 1993 Nov; 41(11):511-6.
        View in: PubMed
      76. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993 Oct; 77(4):956-62.
        View in: PubMed
      77. Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors]. Cardiologia. 1993 Aug; 38(8):519-23.
        View in: PubMed
      78. Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E. [Angiotensin receptors in the rat myocardium during pre- and postnatal development]. Cardiologia. 1993 Jul; 38(7):471-6.
        View in: PubMed
      79. Sechi LA, Valentin JP, Griffin CA, Schambelan M. Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine. Am J Physiol. 1993 Jul; 265(1 Pt 1):G21-7.
        View in: PubMed
      80. Valentin JP, Sechi LA, Qui C, Schambelan M, Humphreys MH. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension. 1993 Apr; 21(4):432-8.
        View in: PubMed
      81. Masharani U, Schambelan M. The endocrine complications of acquired immunodeficiency syndrome. Adv Intern Med. 1993; 38:323-36.
        View in: PubMed
      82. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992 Dec; 71(6):1482-9.
        View in: PubMed
      83. Ray PE, Schambelan M, Hintz R, Ruley EJ, Harrah J, Holliday MA. Plasma renin activity as a marker for growth failure due to sodium deficiency in young rats. Pediatr Nephrol. 1992 Nov; 6(6):523-6.
        View in: PubMed
      84. Sechi LA, Griffin CA, Grady EF, Grunfeld C, Kalinyak JE, Schambelan M. Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes. 1992 Sep; 41(9):1113-8.
        View in: PubMed
      85. al-Uzri A, Holliday MA, Gambertoglio JG, Schambelan M, Kogan BA, Don BR. An accurate practical method for estimating GFR in clinical studies using a constant subcutaneous infusion. Kidney Int. 1992 Jun; 41(6):1701-6.
        View in: PubMed
      86. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol. 1992 Feb; 262(2 Pt 2):F236-40.
        View in: PubMed
      87. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177. J Hypertens Suppl. 1991 Dec; 9(6):S224-5.
        View in: PubMed
      88. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Insulin receptor concentration and gene expression are modulated by sodium intake in the rat kidney. J Hypertens Suppl. 1991 Dec; 9(6):S212-3.
        View in: PubMed
      89. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991 Sep; 88(3):921-33.
        View in: PubMed
      90. Wada L, Don BR, Schambelan M. Hormonal mediators of amino acid-induced glomerular hyperfiltration in humans. Am J Physiol. 1991 Jun; 260(6 Pt 2):F787-92.
        View in: PubMed
      91. Kaysen GA, Don B, Schambelan M. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome. Nephrol Dial Transplant. 1991; 6(2):141-9.
        View in: PubMed
      92. Don BR, Kaysen GA, Hutchison FN, Schambelan M. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. Am J Kidney Dis. 1991 Jan; 17(1):10-7.
        View in: PubMed
      93. Don BR, Schambelan M. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism. Kidney Int. 1990 Dec; 38(6):1159-63.
        View in: PubMed
      94. Anderson PW, Do YS, Schambelan M, Horton R, Boger RS, Luther RR, Hsueh WA. Effects of renin inhibition in systemic hypertension. Am J Cardiol. 1990 Dec 1; 66(19):1342-7.
        View in: PubMed
      95. Farese RV, Schambelan M, Hollander H, Stringari S, Jacobson MA. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis. Ann Intern Med. 1990 Jun 15; 112(12):955-6.
        View in: PubMed
      96. Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M. Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med. 1990 May 3; 322(18):1290-2.
        View in: PubMed
      97. Denolle T, Rohmer V, Saint-Adnré JP, Guyene TT, Galland F, Bigorgne JC, Schambelan M, Corvol P. Effect of the circulating renin-angiotensin system on prolactin release in humans. J Clin Endocrinol Metab. 1990 Jan; 70(1):288-92.
        View in: PubMed
      98. Don BR, Wada L, Kaysen GA, Schambelan M. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome. Kidney Int Suppl. 1989 Nov; 27:S163-7.
        View in: PubMed
      99. Noth RH, Krolewski AS, Kaysen GA, Meyer TW, Schambelan M. Diabetic nephropathy: hemodynamic basis and implications for disease management. Ann Intern Med. 1989 May 15; 110(10):795-813.
        View in: PubMed
      100. Don BR, Blake S, Hutchison FN, Kaysen GA, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in the rat. Am J Physiol. 1989 Apr; 256(4 Pt 2):F711-8.
        View in: PubMed
      101. Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M. Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay. J Clin Invest. 1989 Feb; 83(2):679-87.
        View in: PubMed
      102. Schambelan M, Don BR, Kaysen GA, Blake S. Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration. Adv Exp Med Biol. 1989; 259:275-304.
        View in: PubMed
      103. Hutchinson FN, Schambelan M, Kaysen GA. Modulation of albuminuria by dietary protein and converting enzyme inhibition. Am J Physiol. 1987 Oct; 253(4 Pt 2):F719-25.
        View in: PubMed
      104. Don BR, Schambelan M. Diabetes, dietary protein and glomerular hyperfiltration. West J Med. 1987 Oct; 147(4):449-55.
        View in: PubMed
      105. Sebastian A, Schambelan M. Renal hyperkalemia. Semin Nephrol. 1987 Sep; 7(3):223-38.
        View in: PubMed
      106. Hernandez RE, Schambelan M, Cogan MG, Colman J, Morris RC, Sebastian A. Dietary NaCl determines severity of potassium depletion-induced metabolic alkalosis. Kidney Int. 1987 Jun; 31(6):1356-67.
        View in: PubMed
      107. Schambelan M, Sebastian A, Katuna BA, Arteaga E. Adrenocortical hormone secretory response to chronic NH4Cl-induced metabolic acidosis. Am J Physiol. 1987 Apr; 252(4 Pt 1):E454-60.
        View in: PubMed
      108. Hutchison FN, Don BR, Kaysen GA, Blake S, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in nephrotic rats. Adv Prostaglandin Thromboxane Leukot Res. 1987; 17B:725-8.
        View in: PubMed
      109. Lim RC, Nakayama DK, Biglieri EG, Schambelan M, Hunt TK. Primary aldosteronism: changing concepts in diagnosis and management. Am J Surg. 1986 Jul; 152(1):116-21.
        View in: PubMed
      110. Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1985 Feb; 75(2):404-12.
        View in: PubMed
      111. Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. J Clin Endocrinol Metab. 1985 Feb; 60(2):225-8.
        View in: PubMed
      112. Schambelan M, Sebastian A. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia]. Nephrologie. 1985; 6(3):135-7.
        View in: PubMed
      113. Arteaga E, Biglieri EG, Kater CE, Lopez JM, Schambelan M. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. Ann Intern Med. 1984 Sep; 101(3):316-21.
        View in: PubMed
      114. Maher T, Schambelan M, Kurtz I, Hulter HN, Jones JW, Sebastian A. Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency. J Lab Clin Med. 1984 Mar; 103(3):432-45.
        View in: PubMed
      115. Sebastian A, Schambelan M, Sutton JM. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis. Am J Nephrol. 1984; 4(5):287-300.
        View in: PubMed
      116. Williams FA, Schambelan M, Biglieri EG, Carey RM. Acquired primary hypoaldosteronism due to an isolated zona glomerulosa defect. N Engl J Med. 1983 Dec 29; 309(26):1623-7.
        View in: PubMed
      117. Ardaillou N, Nivez MP, Schambelan M, Ardaillou R. Response of adenylate cyclase to parathyroid hormone and prostaglandins by human isolated glomeruli. J Clin Endocrinol Metab. 1983 Dec; 57(6):1207-15.
        View in: PubMed
      118. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. Effect of diet on plasma acid-base composition in normal humans. Kidney Int. 1983 Nov; 24(5):670-80.
        View in: PubMed
      119. Kater CE, Biglieri EG, Schambelan M, Arteaga E. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism. Hypertension. 1983 Nov-Dec; 5(6 Pt 3):V115-21.
        View in: PubMed
      120. Landefeld CS, Schambelan M, Kaplan SL, Embury SH. Clomiphene-responsive hypogonadism in sickle cell anemia. Ann Intern Med. 1983 Oct; 99(4):480-3.
        View in: PubMed
      121. Kirby BD, Ham J, Fairley HB, Benowitz N, Schambelan M. Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations. West J Med. 1983 Aug; 139(2):221-5.
        View in: PubMed
      122. Sebastian A, Hulter HN, Kurtz I, Maher T, Schambelan M. Disorders of distal nephron function. Am J Med. 1982 Feb; 72(2):289-307.
        View in: PubMed
      123. Jones JW, Sebastian A, Hulter HN, Schambelan M, Sutton JM, Biglieri EG. Systemic and renal acid-base effects of chronic dietary potassium depletion in humans. Kidney Int. 1982 Feb; 21(2):402-10.
        View in: PubMed
      124. Biglieri EG, Schambelan M. Endocrine hypertension. Clin Endocrinol Metab. 1981 Nov; 10(3):ix-xi.
        View in: PubMed
      125. Perloff D, Schambelan M. Renovascular hypertension. Clin Endocrinol Metab. 1981 Nov; 10(3):513-35.
        View in: PubMed
      126. Humphreys MH, Al-Bander H, Eneas JF, Schambelan M. Factors determining electrolyte excretion and renin secretion after closure of an arteriovenous fistula in the dog. J Lab Clin Med. 1981 Jul; 98(1):89-98.
        View in: PubMed
      127. Schambelan M, Sebastian A, Rector FC. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int. 1981 May; 19(5):716-27.
        View in: PubMed
      128. White RH, Schambelan M. Hypertension and angiographic findings in necrotizing vasculitis. Ann Intern Med. 1981 Mar; 94(3):410-1.
        View in: PubMed
      129. Rodriguez JA, Biglieri EG, Schambelan M. Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones. Trans Assoc Am Physicians. 1981; 94:172-82.
        View in: PubMed
      130. White EA, Schambelan M, Rost CR, Biglieri EG, Moss AA, Korobkin M. Use of computed tomography in diagnosing the cause of primary aldosteronism. N Engl J Med. 1980 Dec 25; 303(26):1503-7.
        View in: PubMed
      131. Sebastian A, Sutton JM, Hulter HN, Schambelan M, Poler SM. Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients. Kidney Int. 1980 Dec; 18(6):762-73.
        View in: PubMed
      132. Benowitz NL, Byrd R, Schambelan M, Rosenberg J, Roizen MF. Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide. Ann Intern Med. 1980 Mar; 92(3):387-8.
        View in: PubMed
      133. White RH, Schambelan M. Hypertension, hyperreninemia, and secondary hyperaldosteronism in systemic necrotizing vasculitis. Ann Intern Med. 1980 Feb; 92(2 Pt 1):199-201.
        View in: PubMed
      134. Hulter HN, Sebastian A, Sigala JF, Licht JH, Glynn RD, Schambelan M, Biglieri EG. Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog: role of aldosterone. Am J Physiol. 1980 Feb; 238(2):F79-91.
        View in: PubMed
      135. Schambelan M, Sebastian A, Biglieri EG. Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int. 1980 Jan; 17(1):89-101.
        View in: PubMed
      136. Biglieri EG, Brust N, Chang B, Hirai J, Wajchenberg BL, Schambelan M. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones. Prog Biochem Pharmacol. 1980; 17:36-43.
        View in: PubMed
      137. Biglieri EG, Chang B, Hirai J, Brust N, Rost CR, Schambelan M. Adrenocorticotropin inhibition of mineralocorticoid hormone production. Clin Sci (Lond). 1979 Dec; 57 Suppl 5:307s-311s.
        View in: PubMed
      138. Biglieri EG, Schambelan M. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab. 1979 Jul; 49(1):87-91.
        View in: PubMed
      139. Schambelan M, Sebastian A. Hyporeninemic hypoaldosteronism. Adv Intern Med. 1979; 24:385-405.
        View in: PubMed
      140. Sebastian A, Schambelan M, Lindenfeld S, Morris RC. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med. 1977 Sep 15; 297(11):576-83.
        View in: PubMed
      141. Hogan MJ, Schambelan M, Biglieri EG. Concurrent hypercortisolism and hypermineralocorticoidism. Am J Med. 1977 May; 62(5):777-82.
        View in: PubMed
      142. Potter DE, Schambelan M, Salvatierra O, Orloff S, Holliday MA. Treatment of high-renin hypertension with propranolol in children after renal transplantation. J Pediatr. 1977 Feb; 90(2):307-11.
        View in: PubMed
      143. Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Bartter FC. Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors. Clin Sci Mol Med Suppl. 1976 Dec; 3:321s-324s.
        View in: PubMed
      144. Matulich DT, Spindler BJ, Schambelan M, Baxter JD. Mineralocorticoid receptors in human kidney. J Clin Endocrinol Metab. 1976 Nov; 43(5):1170-4.
        View in: PubMed
      145. Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Taylor AA, Bartter FC. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states. J Clin Invest. 1976 Sep; 58(3):579-89.
        View in: PubMed
      146. Kershnar AK, Borut D, Kogut MD, Biglieri EG, Schambelan M. Studies in a phenotypic female with 17-alpha-hydroxylase deficiency. J Pediatr. 1976 Sep; 89(3):395-400.
        View in: PubMed
      147. Schambelan M, Brust NL, Chang BC, Slater KL, Biglieri EG. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab. 1976 Jul; 43(1):115-31.
        View in: PubMed
      148. Hogan MJ, McRae J, Schambelan M, Biglieri EG. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol. N Engl J Med. 1976 Feb 19; 294(8):410-4.
        View in: PubMed
      149. Korobkin M, Glickman MG, Schambelan M. Segmental renal vein sampling for renin. Radiology. 1976 Feb; 118(2):307-13.
        View in: PubMed
      150. Hunt TK, Schambelan M, Biglieri EG. Selection of patients and operative approach in primary aldosteronism. Ann Surg. 1975 Oct; 182(4):353-61.
        View in: PubMed
      151. Schambelan M. Letter: Hyporeninemic hypoaldosteronism in chronic renal disease. Metabolism. 1975 Jun; 24(6):793-4.
        View in: PubMed
      152. Clark OH, Hall AD, Schambelan M. Clinical manifestations of adrenal hemorrhage. Am J Surg. 1974 Aug; 128(2):219-24.
        View in: PubMed
      153. Schambelan M, Glickman M, Stockigt JR, Biglieri EG. Selective renal-vein renin sampling in hypertensive patients with segmental renal lesions. N Engl J Med. 1974 May 23; 290(21):1153-7.
        View in: PubMed
      154. Golde DW, Schambelan M, Weintraub BD, Rosen SW. Gonadotropin-secreting renal carcinoma. Cancer. 1974 Apr; 33(4):1048-53.
        View in: PubMed
      155. Eichner HL, Schambelan M, Biglieri EG. Systemic lupus erythematosus with adrenal insufficiency. Am J Med. 1973 Nov; 55(5):700-5.
        View in: PubMed
      156. Stockigt JR, Hertz P, Schambelan M, Biglieri EG. Segmental renal-vein renin sampling for segmental renal infarction. Studies in a hypertensive patient. Ann Intern Med. 1973 Jul; 79(1):67-70.
        View in: PubMed
      157. Schambelan M, Howes EL, Noakes CA, Biglieri EG. Role of renin and aldosterone in hypertension due to a renin-secreting tumor. Am J Med. 1973 Jul; 55(1):86-92.
        View in: PubMed
      158. Schambelan M, Stockigt JR, Biglieri EG. Isolated hypoaldosteronism in adults. A renin-deficiency syndrome. N Engl J Med. 1972 Sep 21; 287(12):573-8.
        View in: PubMed
      159. Stockigt JR, Collins RD, Noakes CA, Schambelan M, Biglieri EG. Renal-vein renin in various forms of renal hypertension. Lancet. 1972 Jun 3; 1(7762):1194-7.
        View in: PubMed
      160. Biglieri EG, Stockigt JR, Schambelan M. Adrenal mineralocorticoids causing hypertension. Am J Med. 1972 May; 52(5):623-32.
        View in: PubMed
      161. Schambelan M, Biglieri EG. Deoxycorticosterone production and regulation in man. J Clin Endocrinol Metab. 1972 Apr; 34(4):695-703.
        View in: PubMed
      162. Schambelan M, Slaton PE, Biglieri EG. Mineralocorticoid production in hyperadrenocorticism. Role in pathogenesis of hypokalemic alkalosis. Am J Med. 1971 Sep; 51(3):299-303.
        View in: PubMed
      163. Biglieri EG, Stockigt JR, Schambelan M. A preliminary evaluation for primary aldosteronism. Arch Intern Med. 1970 Dec; 126(6):1004-7.
        View in: PubMed
      164. Biglieri EG, Schambelan M, Slaton PE, Stockigt JR. The intercurrent hypertension of primary aldosteronism. Circ Res. 1970 Jul; 27(1 Suppl 1):195-202.
        View in: PubMed
      165. Schambelan M, Slaton PE, Murray JF, Biglieri EG. Adrenal insufficiency and inappropriate secretion of antidiuretic hormone. Occurrence in a patient with carcinoma of the lung. Arch Intern Med. 1969 Aug; 124(2):197-201.
        View in: PubMed
      166. Slaton PE, Schambelan M, Biglieri EG. Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma. J Clin Endocrinol Metab. 1969 Feb; 29(2):239-50.
        View in: PubMed
      167. Biglieri EG, Slaton PE, Schambelan M, Kronfield SJ. Hypermineralocorticoidism. Am J Med. 1968 Aug; 45(2):170-5.
        View in: PubMed
      168. Schambelan M, Sussman S. Encephalitis and purpura with influenza infection. A case report. Am J Dis Child. 1966 Mar; 111(3):302-3.
        View in: PubMed
      Morris's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP